Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 9, 2010
Issued Date -
N/A
app pub date -
Nov 7, 2008
filing date -
Nov 8, 2007
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides for recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens, along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to the nucleic acids, and uses for these antibodies, nucleic acids and amino acids.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully